BR0109496A - Uso de bactéria do ácido láctico para o tratamento de peritonite - Google Patents

Uso de bactéria do ácido láctico para o tratamento de peritonite

Info

Publication number
BR0109496A
BR0109496A BR0109496-3A BR0109496A BR0109496A BR 0109496 A BR0109496 A BR 0109496A BR 0109496 A BR0109496 A BR 0109496A BR 0109496 A BR0109496 A BR 0109496A
Authority
BR
Brazil
Prior art keywords
treatment
peritonitis
lactic acid
acid bacteria
relates
Prior art date
Application number
BR0109496-3A
Other languages
English (en)
Inventor
Eduardo Schiffrin
Carlos Guarner
German Soriano
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of BR0109496A publication Critical patent/BR0109496A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/151—Johnsonii
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)

Abstract

"USO DE BACTéRIA DO áCIDO LáCTICO PARA O TRATAMENTO DE PERITONITE". A presente invenção refere-se ao uso de bactérias de ácido láctico capazes de aderir a mucosa do intestino e essencialmente colonizar o mesmo para o tratamento de distúrbios associados à peritonite. Especificamente, a presente invenção refere-se ao uso de tais bactérias de ácido láctico para o tratamento de peritonite causada por cirrose hepática.
BR0109496-3A 2000-03-24 2001-03-22 Uso de bactéria do ácido láctico para o tratamento de peritonite BR0109496A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00106441 2000-03-24
PCT/EP2001/003271 WO2001070246A1 (en) 2000-03-24 2001-03-22 Use of lactic acid bacterium for the treatment of peritonitis

Publications (1)

Publication Number Publication Date
BR0109496A true BR0109496A (pt) 2002-12-10

Family

ID=8168228

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0109496-3A BR0109496A (pt) 2000-03-24 2001-03-22 Uso de bactéria do ácido láctico para o tratamento de peritonite

Country Status (22)

Country Link
US (2) US7217414B2 (pt)
EP (1) EP1276488B1 (pt)
JP (1) JP2003527432A (pt)
KR (1) KR20020087418A (pt)
CN (1) CN1183916C (pt)
AR (1) AR028288A1 (pt)
AT (1) ATE348626T1 (pt)
AU (1) AU783439C (pt)
BG (1) BG107096A (pt)
BR (1) BR0109496A (pt)
CA (1) CA2403491A1 (pt)
DE (1) DE60125345T2 (pt)
ES (1) ES2276793T3 (pt)
HK (1) HK1052465B (pt)
HU (1) HUP0301059A3 (pt)
IL (2) IL151596A0 (pt)
MX (1) MXPA02009342A (pt)
NO (1) NO20024488D0 (pt)
PL (1) PL358214A1 (pt)
UA (1) UA76104C2 (pt)
WO (1) WO2001070246A1 (pt)
ZA (1) ZA200208592B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100845456B1 (ko) * 2001-02-06 2008-07-10 소시에떼 데 프로듀이 네슬레 소시에떼아노님 젖산균 및 비피도균에 의한 내독소 결합
EP1408760B1 (en) * 2001-02-19 2009-04-01 Société des Produits Nestlé S.A. Consumable product containing probiotics
EP1478242B1 (en) * 2002-02-21 2014-04-30 Societe Des Produits Nestle S.A. Pet food composition for skin photoprotection
MXPA04008177A (es) * 2002-02-21 2005-06-08 Nestle Sa Composicion oralmente administrable, para la fotoproteccion de la piel.
CA2476730C (en) * 2002-02-21 2012-07-10 Lionel Breton A photoprotective orally administrable composition for skin
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
AU2006296837B2 (en) 2005-09-28 2012-12-13 Nordic Rebalance A/S Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors
DK1992351T3 (en) * 2007-05-18 2016-06-06 Nestec Sa Lactobacillus johnsonii for the prevention of post-surgical infection
ATE537707T1 (de) * 2008-05-16 2012-01-15 Nestec Sa Lactobacillus paracasei und gewichtskontrolle
CA2761444C (en) * 2009-05-11 2018-04-24 Nestec S.A. Lactobacillus johnsonii la1 ncc533 (cncm i-1225) and immune disorders
GB0914878D0 (en) 2009-08-26 2009-09-30 Plant Bioscience Ltd Competetive exclusion compositions and methods
CN105816484A (zh) * 2015-01-07 2016-08-03 东宇生物科技股份有限公司 用于腹膜透析病患预防腹膜炎并减少肾功能恶化的组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1723116A1 (ru) * 1988-04-15 1992-03-30 Оренбургский Государственный Медицинский Институт Штамм бактерий BacILLUS SUвтILIS, используемый дл получени препарата дл профилактики и лечени воспалительных процессов и аллергических заболеваний
JPH04264034A (ja) 1991-02-18 1992-09-18 Snow Brand Milk Prod Co Ltd 生体内過酸化脂質抑制剤
US5716615A (en) 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
DE69219768T2 (de) * 1992-07-06 1997-08-28 Societe Des Produits Nestle S.A., Vevey Milchbakterien
JP2712000B2 (ja) 1994-12-22 1998-02-10 ニチニチ製薬株式会社 Ｃ型肝炎治療剤
SE9501719D0 (sv) 1995-05-09 1995-05-09 Probi Ab Pharmaceutical composition
US6562629B1 (en) * 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
JPH09301877A (ja) 1996-05-13 1997-11-25 Youshindou:Kk 肝炎治療・予防剤
CN1084599C (zh) * 1996-09-06 2002-05-15 雀巢制品公司 带含乳酸菌包覆层的膨化冰淇淋
ES2164299T5 (es) * 1997-01-09 2009-03-01 Societe Des Produits Nestle S.A. Producto cereal que contiene probioticos.
IT1289984B1 (it) 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
NZ501787A (en) * 1997-07-05 2001-08-31 Nestle Sa Frozen dessert comprising ice cream containing probiotic lactic acid bacteria and a support free of bacteria containing fermentable fibres
RO112995B1 (ro) * 1997-08-05 1998-03-30 Rodica Teodorescu Produs medicamentos pentru terapia colonului
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof

Also Published As

Publication number Publication date
EP1276488B1 (en) 2006-12-20
DE60125345D1 (de) 2007-02-01
WO2001070246A1 (en) 2001-09-27
MXPA02009342A (es) 2003-09-22
US20030044397A1 (en) 2003-03-06
CN1183916C (zh) 2005-01-12
BG107096A (bg) 2003-05-30
AU783439C (en) 2006-12-14
US20070172512A1 (en) 2007-07-26
AU6212701A (en) 2001-10-03
CA2403491A1 (en) 2001-09-27
UA76104C2 (en) 2006-07-17
IL151596A (en) 2008-07-08
US7678370B2 (en) 2010-03-16
ZA200208592B (en) 2004-02-10
JP2003527432A (ja) 2003-09-16
AU783439B2 (en) 2005-10-27
NO20024488L (no) 2002-09-19
AR028288A1 (es) 2003-04-30
ES2276793T3 (es) 2007-07-01
KR20020087418A (ko) 2002-11-22
NO20024488D0 (no) 2002-09-19
IL151596A0 (en) 2003-04-10
HUP0301059A3 (en) 2004-10-28
ATE348626T1 (de) 2007-01-15
HK1052465A1 (en) 2003-09-19
US7217414B2 (en) 2007-05-15
HK1052465B (zh) 2007-05-11
EP1276488A1 (en) 2003-01-22
PL358214A1 (en) 2004-08-09
HUP0301059A2 (hu) 2003-07-28
DE60125345T2 (de) 2007-09-27
CN1419454A (zh) 2003-05-21

Similar Documents

Publication Publication Date Title
BR0109496A (pt) Uso de bactéria do ácido láctico para o tratamento de peritonite
IT1306716B1 (it) Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
BRPI0417823A (pt) métodos para uso de bifidobactérias probióticas para animais de estimação
DE69924141D1 (de) Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
BR0315209A (pt) Formulações nutritivas que contêm substâncias simbióticas
BR9909668A (pt) Uso de compostos de organofósforo para o tratamento terapêutico e profilático de infecções
BR0214705A (pt) Composição, seu uso, método para prevenção ou tratamento de doença neurodegenerativa, e kit
ID24734A (id) Bakteri asam laktat yang meningkatkan kekebalan
BR9904939A (pt) Poliorganossilloxanos de enxofre-funcionais
DE69905170T2 (de) Thiazolopyrimidinderivate
RS8504A (en) Novel cyclohexil sulphones
ATE312104T1 (de) Verbindungen zur behandlung von beeinträchtigten fundischen entspannung
ATA118295A (de) (s)-hydroxynitrillyase aus hevea brasiliensis
BRPI0409609A (pt) mediadores do transporte reverso de colesterol para o tratamento da hipercolesterolemia
BR9911005A (pt) Uso de ozÈnio para a preparação de medicamentos para o tratamento de cáries dentárias
BR0005061A (pt) Secreção de ácido gástrico
MXPA02012857A (es) Uso de una formulacion elaborada de o que contiene al menos un suero de leche dismilado.
FR2779917B1 (fr) Elements ingerables
BRPI0210317C1 (pt) complexo de vacina terapêutica destinado à prevenção ou ao tratamento de leishmanioses e infecções mediadas por microorganismos patogênicos intracelulares nos mamíferos
PT640098E (pt) Gene de coronavirus canino e suas utilizacoesc
BR0313230A (pt) Uso de carboxamidas para o tratamento de tinido
NO20005548D0 (no) Mykobakterieinhibitorer
HUP0003845A2 (hu) Antimikrobiális 8a-azalidok alkalmazása
BR0211533A (pt) Tratamento de dor crÈnica com 3-heterociclil- e 3-cicloalquil-3-ariloxipropanaminas
DE69923117D1 (de) Verwendung von Homocysteinderivaten zur Behandlung von bakteriellen Infektionen

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11 E 13 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.

B15K Others concerning applications: alteration of classification

Ipc: A61K 35/747 (2015.01), A23L 29/00 (2016.01), A23L